MedCity News

Mount Sinai Drops Anthem Following Contract Dispute

Doctors and the Virtual Medical Revolution and Technological Advances Artificial Intelligence (AI) Deep Learning for Medical Research and Future Health Technology

Third Way Health Secures $15M to Streamline Front-Office Operations for Medical Practices

Third Way Health's Series A round was from Health Velocity Capital, led by partner Kristin Torres Mowat. In total, Third Way Health has raised $22.5 million.

By Marissa Plescia

BioPharma, Legal

Moderna to Pay Up to $2.25B to Settle Patent Suit Over Covid-19 Vaccine Technology

Under the settlement, Genevant Sciences and Arbutus Biopharma will grant Moderna a non-exclusive license to their lipid nanoparticle technology for mRNA delivery in infectious disease vaccines. If Moderna's full financial payout to the companies is reached, it would rank among the largest disclosed patent settlements in biopharmaceutical industry history.

By Frank Vinluan

MedCity Influencers

AI, VR, and the Training Gap: Why New Healthcare Tech Fails Without Workforce Readiness

The problem isn’t whether these modalities work, but how they’re being implemented into the workforce. Efficient rollout, proper training, and ongoing education are vital for these new methods to reach their full potential.

By Lora Sparkman

Latest Video

Latest News

Artificial Intelligence, Hospitals, Startups, Health Tech

Female worker turning to face the camera while sitting in the office of a clinical analysis laboratory

Why Mount Sinai Chose Microsoft Over Abridge and Suki

Mount Sinai Health System is betting on Microsoft’s Dragon Copilot as its ambient scribing tool of choice, a decision that followed competitive tests against rival vendors Abridge and Suki. Lisa Stump, Mount Sinai’s chief digital information officer, noted that the health system has been transparent with Microsoft that their partnership may change given Epic’s launch of a built-in AI charting tool earlier this month.

By Katie Adams

The Power of One: Redefining Healthcare with an AI-Driven Unified Platform

In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.

By David Cohen, Chief Product & Technology Officer, Greenway Health

BioPharma, Legal

Moderna Says FDA Refusal to Review mRNA Flu Vaccine Contradicts Federal Rules, Prior Guidance

The FDA’s refuse-to-file letter cited no safety or efficacy concerns for Moderna’s influenza vaccine, mRNA-1010. The company said the agency’s justification for refusing a review is inconsistent with guidance given prior to the start of Phase 3 testing.

By Frank Vinluan

MedCity Influencers

AI-powered creative writing and education concept. Futuristic chatbot with digital pencil. Smart learning, content creation, and automation. Modern vector illustration on dark blue background

From Claims Payer to Care Partner: What AI Really Changes in Health Insurance, and What It Doesn’t

AI can help health plans reduce friction, speed revenue-cycle throughput, and improve member experience, but only when it is deployed with strong data discipline, modern integration patterns, and a governance model that treats AI as “augmented intelligence,” meaning powerful, assistive, and accountable.

By Chris House

MedCity Influencers

The Next Frontier of Interoperability: Additional Clinical Data Sources – Dentistry, Devices, Social Care, and More

Healthcare cannot achieve its goals for quality, equity, and value without breaking down the persistent barriers that keep critical information siloed across sectors.

By Steven Lane

MedCity Influencers

Medicare Advantage’s Discipline Era — and Why the Final Rate Notice Matters More Than It Appears

The challenge for policymakers is balance: encouraging rigor without unintentionally weakening a program that now serves the majority of Medicare beneficiaries. Thoughtful rate calibration can determine whether this transition strengthens the program or strains it unnecessarily.

By Sachin H. Jain

BioPharma, Pharma

Evommune Starts Making Case to Challenge Dominance of Sanofi’s Dupixent in Atopic Dermatitis

Evommune’s EVO301 met the goals of a placebo-controlled Phase 2a study in atopic dermatitis. The biologic drug neutralizes a signaling protein involved in multiple inflammatory pathways, which could differentiate it from the blockbuster Sanofi and Regeneron Pharmaceuticals immunology drug Dupixent.

By Frank Vinluan

Artificial Intelligence

A mechanical hand with dots hovering over it and a pill showing AI and medicine

Lilly’s Chief Information & Digital Officer: AI Use Goes Far Beyond Just Drug Discovery

Elli Lilly has been in the news lately because of the announced $1 billion investment in a joint innovation lab with Nvidia, an AI powerhouse player. But AI drug discovery is only part of the story of where AI can be leveraged in biopharma.

By Arundhati Parmar

Health Tech, Startups

Real white unicorn in field with rainbow

Solace Health Reaches Unicorn Status by Taking the ‘Homework’ Out of Care Navigation

Health advocate network Solace Health gained unicorn status after closing a $130 million Series C funding round. The startup’s advocates help with tasks like scheduling appointments, finding in-network providers, understanding insurance coverage and bills, and coordinating care across multiple clinicians. And they actually handle much of the work on a patient’s behalf, rather than simply telling patients what steps to take next.

By Katie Adams

MedCity Influencers

Digital generated image of arrow sign made out of cubes connected together into pattern on white background.

From Pandemic Urgency to Practical Impact: How Diagnostics Investment Priorities Are Evolving

Speed still matters, but there’s been a shift in the industry. It’s not enough to be scientifically sound. Now, practicality is of utmost importance.

By Jamie Platt

MedCity Influencers

The Next Stage in At-Home Healthcare is Arriving

The new era is more predictive, assistive, and actionable. But providers and patients need to know what to look for.

By Al Woo

Top Story

Take Control of Your Healthcare News: Add MedCity News to Your Google Preferred Sources

Make us a preferred source to get incisive news and analysis on healthcare and life science companies when you need it.

By MedCity News

Health Tech, Hospitals, Startups, Providers

Senior woman using smartphone at kitchen table

NYU Langone Taps Isaac Health for New Virtual Dementia Care Model

NYU Langone Health is partnering with Isaac Health to launch a specialist-led virtual care model aimed at reducing long waits for memory care. The partnership will test whether telehealth can expand access without sacrificing quality as demand for neurologists continues to outpace supply.

By Katie Adams